Questions discussed in this category
The patient previously received endocrine therapy alone and in combination with CDK 4/6 inhibitor. She does not have any targetable mutations on NGS. ...
Patient is a post-menopausal woman with 4 lymph node mets that was strongly ER+/PR+, HER2-negative invasive ductal carcinoma with a high Ki-67 w...
In a patient with a history of VTE (now off anticoagulants), is it safe to administer fulvestrant?
In which situations would you consider this a reasonable treatment option?
The patient is treatment naïve and asymptomatic. She also has disease in the body (bone and liver metastases).
The patient initially received definitive therapy with AC-T and RT to the breast as well as RT to a solitary bone lesion. She has been on AI for the l...
Do you have a specific age cutoff?
The patient was diagnosed with Ewing’s Sarcoma at the age of 10 and completed 6 cycles of vincristine, ifosfamide, etoposide, adriamycin 75mg/m2...
110141283111629109731081710821103271015910164
Papers discussed in this category
J Clin Oncol, 2019 Apr 11
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-08-10
The New England journal of medicine, 2018-07-12
N Engl J Med, 2021 Apr 22
N Engl J Med,
J. Clin. Oncol., 2020 Sep 20
Clin Cancer Res, 2020 Jan 1
JAMA Oncol, 2019 Sep 29
J Clin Oncol, 2021 Mar 26
The New England journal of medicine, 2012-02-09
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 May 19
N. Engl. J. Med.,
N Engl J Med,
N Engl J Med, 2022 Jun 05
J Clin Oncol, 2022 May 18
The New England journal of medicine, 2023 Jun 01
Lancet (London, England), 2023 Aug 23
Breast Cancer Res Treat, 2018 Jul 04
Eur J Haematol, 2021 Feb 18
Lancet (London, England), 2014-07-12
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012-05-20
N Engl J Med, 2021 Jun 03